CorMedix (CRMD) Capital Expenditures (2010 - 2025)

CorMedix has disclosed Capital Expenditures across 12 years of filings, most recently posting $1.7 million for Q4 2025.

• Capital Expenditures for Q4 2025 came in at $1.7 million, up 16865.22% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.3 million (up 1848.28% YoY), and the FY2025 annual result was $2.3 million, up 1848.28% from the prior year.
• Capital Expenditures came in at $1.7 million for Q4 2025 at CorMedix, up from $505774.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $1.7 million in Q4 2025 to a low of $4324.0 in Q1 2022.
• The 5-year median for Capital Expenditures is $19355.5 (2023), against an average of $217399.4.
• Across the five-year window, Capital Expenditures sank 96.57% in 2024 and surged 16865.22% in 2025, its largest moves.
• CorMedix's Capital Expenditures stood at $628761.0 in 2021, then tumbled by 79.52% to $128755.0 in 2022, then jumped by 129.84% to $295931.0 in 2023, then tumbled by 96.57% to $10139.0 in 2024, then soared by 16865.22% to $1.7 million in 2025.
• The last three Capital Expenditures figures came in at $1.7 million (Q4 2025), $505774.0 (Q3 2025), and $23945.0 (Q2 2025), per Business Quant data.